Medtronic Aktie
WKN DE: A14M2J / ISIN: IE00BTN1Y115
19.09.2025 14:52:40
|
Medtronic's Altaviva Device Wins US FDA Approval
(RTTNews) - Medtronic plc (MDT), Friday announced that its Altaviva device, designed to treat urge urinary incontinence, has secured U.S. Food and Drug Administration approval.
Designed for real-life needs, the Altaviva device is MRI-compatible, providing patients with peace of mind for planned or unexpected medical imaging, the company stated.
The device is inserted near the ankle during a minimally invasive procedure. It sits slightly below the skin and sends electrical impulses to the tibial nerve, helping restore communication between the bladder and the brain to regulate bladder control.
In the pre-market hours, MDT is trading at $96.05, up 0.49 percent on the New York Stock Exchange.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Medtronic PLCmehr Nachrichten
Analysen zu Medtronic PLCmehr Analysen
Aktien in diesem Artikel
Medtronic PLC | 81,55 | 1,20% |
|